Showing 1831-1840 of 2755 results for "".
- Coming This Week: Cutera AviClear Webinarhttps://modernaesthetics.com/news/coming-this-week-cutera-aviclear-webinar/2473230/Cutera hosts the first webinar for AviClear, the first and only FDA cleared energy-based device for the treatment of mild, moderate, and severe acne, this week. Dermatologists Jeffrey S. Dover, MD, FRCPC and Julie C. Harper, MD will discuss the latest advancement in the treatment of acn
- Colorescience, Aesthetics Biomedical Join Forces for New Collabhttps://modernaesthetics.com/news/colorescience-aesthetics-biomedical-join-forces-for-new-collab/2473229/Colorescience and Aesthetics Biomedical are launching a collaboration that combines Vivace Microneedle RF with a post-treatment protocol featuring Colorescience’s Sunforgettable Total Protection Brush-On Shield SPF 50. Patients opting for the radiofrequency microneedlin
- Elevai Labs Names Chief Marketing and Brand Advisorhttps://modernaesthetics.com/news/elevai-labs-names-chief-marketing-and-brand-advisor/2473228/Brenda Buechler is now Chief Marketing and Brand Advisor for Elevai Labs, Inc. Elevai is a science-based aesthetic skincare company providing topical formulations featuring by ethically sourced, human umbilical mesenchymal stem cells (hUMSC)-derived e
- New from Lumenis: triLift Targets Three Elements of Aginghttps://modernaesthetics.com/news/new-form-lumenis-trilift-targets-three-elements-of-aging/2473227/Lumenis Be, Ltd., has launched triLift, a facial stimulation device targeting three aging elements—structure, contour, and texture—by treating the three tissue layers. The device affects the muscl
- Revance News: FDA Accepts BLA Resubmission for DaxibotulinumtoxinAhttps://modernaesthetics.com/news/revance-news-fda-accepts-bla-resubmission-for-daxibotulinumtoxina/2473223/The U.S. Food and Drug Administration (FDA) accepted Revance’s Biologics License Application (BLA) resubmission for DaxibotulinumtoxinA for Injection for the treatment of moderate to severe glabellar lines. The FDA designated the BLA as a Class 2 resubmission, which has a six-mont
- Cutera Invites ASLMS Attendees to Celebrate AviClear Launchhttps://modernaesthetics.com/news/cutera-invites-aslms-attendees-to-celebrate-aviclear-launch/2473222/Cutera is celebrating the launch of AviClear during the ASLMS meeting in San Diego, and meeting attendees are invited to join the festivities. AviClear is the first and only FDA cleared energy-based device for the treatment of mild, moderate, and severe acne, The AviClear laun
- PatientFi and The Aesthetic Society Form Alliance Partnershiphttps://modernaesthetics.com/news/patientfi-and-the-aesthetic-society-form-alliance-partnership/2473220/The Aesthetic Society and PatientFi entered into an Alliance Partnership to benefit members. PatientFi offers financing solution to help more patients afford the treatments and procedures they want, which, in turn, helps providers grow their case vol
- Suneva's Silhouette InstaLift Recognized with New Beauty Awardhttps://modernaesthetics.com/news/sunevas-silhouette-instalift-recognized-with-new-beauty-award/2473219/Suneva Medical, Inc.'s non-surgical thread lift, Silhouette InstaLift®, is the Best Thread Lift Treatment in NewBeauty's 2022 Beauty Awards. It uses collagen-stimulating absorbable sutures that offer patients immediate and lasting results with minimal recovery time.
- New Aesthetic Society Data: Facelifts, Breast Procedures, and Body Procedures Surged in 2021https://modernaesthetics.com/news/new-aesthetic-society-data-facelifts-breast-procedures-and-body-procedures-surged-in-2021/2473217/Plastic surgery is booming, according to the Aesthetic Society’s annual
- PatientFi, Allergan Expand Co-marketing Agreementhttps://modernaesthetics.com/news/patientfi-allergan-expand-co-marketing-agreement/2473214/PatientFi® is expanding its co-marketing agreement with Allergan Aesthetics, an AbbVie company, to provide financing options for patients interested in treatments such as BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM®Collection of Fillers, Natrelle® breast i